Clinical trials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 5 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| No longer available | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 11 |
| Pfizer | 5 |
| Bristol-Myers Squibb | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 2 |
| Enliven Therapeutics | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Sun Pharma Advanced Research Company Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 25 |
| Leukemia | 6 |
| Bronchiolitis Obliterans Syndrome | 4 |
| Philadelphia Chromosome | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Bone Marrow Diseases | 3 |
| Hematologic Diseases | 2 |
| Hematologic Neoplasms | 2 |
| Leukemia, Myeloid | 2 |
| Myeloproliferative Disorders | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.